Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbiomed, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2022 | Q2 2023 | $2.34 | $265.92 M | |||
| 08/04/2022 | Q1 2023 | $1.06 | $1.20 | 0.14 | $277.15 M | |
| 05/20/2022 | Q4 2022 | $1.33 | $269.85 M | |||
| 02/03/2022 | Q3 2022 | $0.95 | $1.01 | 0.06 | $261.18 M | |
| 10/28/2021 | Q2 2022 | $0.97 | $1.25 | 0.28 | $248.14 M | |
| 08/05/2021 | Q1 2022 | -$0.59 | $252.59 M | |||
| 05/21/2021 | Q4 2021 | $1.26 | $241.25 M | |||
| 02/04/2021 | Q3 2021 | $1.37 | $231.66 M | |||
| 11/06/2020 | Q2 2021 | $1.38 | $209.76 M | |||
| 08/06/2020 | Q1 2021 | $0.29 | $0.99 | 0.7 | $164.85 M | |
| 05/21/2020 | Q4 2020 | $0.71 | $206.66 M | |||
| 02/06/2020 | Q3 2020 | $1.09 | $1.53 | 0.44 | $221.58 M | |
| 10/31/2019 | Q2 2020 | $0.93 | $0.29 | -0.64 | $204.97 M | |
| 08/01/2019 | Q1 2020 | $0.97 | $1.97 | 1 | $207.67 M | |
| 05/23/2019 | Q4 2019 | $1.64 | $207.08 M | |||
| 02/05/2019 | Q3 2019 | $1.00 | $200.56 M | |||
| 11/06/2018 | Q2 2019 | $1.11 | $181.78 M | |||
| 08/02/2018 | Q1 2019 | $2.02 | $180.01 M | |||
| 05/24/2018 | Q4 2018 | $0.83 | $174.44 M | |||
| 02/06/2018 | Q3 2018 | $0.30 | $154.02 M |
Abiomed, Inc. Earnings: FAQ's
When is Abiomed, Inc.'s earnings date?
Abiomed, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, October 29th, 2023 based off last year's report dates.
Did Abiomed, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Abiomed, Inc. (:ABMD) reported $1.3 earnings per share (EPS) to beat the analysts' consensus estimate of $1.04 by $0.26.
How can I listen to Abiomed, Inc.'s earnings conference
call?
The conference call for Abiomed, Inc.'s latest earnings report can be listened to online.
How can I read Abiomed, Inc.'s conference call transcript?
The conference call transcript for Abiomed, Inc.'s latest earnings report can be read online.
How much revenue does Abiomed, Inc. generate each year?
Abiomed, Inc. (:ABMD) has a recorded annual revenue of $1.03 B.
How much profit does Abiomed, Inc. generate each year?
Abiomed, Inc. (:ABMD) has a recorded net income of $1.03 B. Abiomed, Inc. has generated $3 earnings per share over the last four quarters.
What is Abiomed, Inc.'s price-to-earnings ratio?
Abiomed, Inc. (:ABMD) has a price-to-earnings ratio of 126.85 and price/earnings-to-growth ratio is 1.27.